Upcoming Global IPOs
Shenzhen Longsys Electronics Co., Ltd. (Ticker: 9976 HK) is a Chinese semiconductor memory products company that designs, develops, back-end manufactures and sells storage and memory products for consumer, enterprise and industrial applications. The company operates the FORESEE, Zilia and Lexar brands and does not manufacture memory wafers, instead sourcing wafers and controller chips from third-party suppliers.
Shenzhen Longsys plans to list on the Hong Kong Stock Exchange on September 8, 2026. The IPO is priced at HKD 236.00 per share, below the indicated HKD 240.60 range, with approximately 26.08 million shares offered. The base offering is expected to raise approximately HKD 6.15 billion, or approximately $785 million. All shares in the base offering are primary shares, with a 15% greenshoe covering approximately 3.91 million additional shares.
The offering is being managed by firms including ABCI Capital, CLSA, China Securities International, Citigroup Global Markets Asia and Futu Securities International.
Excelland Robotics (Wuxi) Co. Ltd. (Ticker: 3231 HK) is a Chinese technology company that develops and commercializes commercial service robots, robotic modules and AI vision model solutions. Its products include delivery and cleaning robots, low-speed unmanned vehicles, robot-as-a-service and rental offerings, while its Yoware platform provides AI vision solutions for non-robot industrial applications.
Excelland Robotics plans to list on the Hong Kong Stock Exchange on September 9, 2026 under Chapter 18C of the Listing Rules, meaning that it is listing as a specialist technology company under Hong Kong’s dedicated regime for eligible technology businesses. The company is offering 45.0 million primary shares at an expected price range of HKD 14.45 to HKD 19.55 per share. The IPO is expected to raise approximately HKD 880 million, or approximately $112 million. The offering is being managed by a syndicate including CEB International Capital, CMBC Securities, DL Securities, Get Nice Securities, Guosen Securities HK Brokerage and Harmonia Capital.
KOMPEITO Inc. (Ticker: 618A JP) is a Japanese food services company focused on workplace food and employee welfare solutions. Its core “OFFICE DE YASAI” service provides healthy meals, including salads and boxed meals, through refrigerators and freezers installed in offices. The company also operates in the United States through subsidiaries including KOMPEITO USA Inc.
KOMPEITO plans to list on the Tokyo Stock Exchange Growth Market on September 11, 2026. The IPO was priced at JPY 1,600 per share, at the top of the JPY 1,560-1,600 range. The offering comprises approximately 4.19 million shares, raising approximately JPY 6.70 billion (approximately $42 million), before a potential 628,200-share overallotment. Approximately 98.8% of the offering consists of secondary shares, with only 50,000 primary shares issued by the company. The implied market capitalization at the offer price is approximately JPY 15.84 billion, or around $99 million. SBI Securities is the lead manager.
Oliver Corporation (Ticker: 619A JP) is a Japanese commercial services company providing end-to-end interior solutions, spanning planning, design, consulting, project management, furniture manufacturing and interior construction. The company serves offices, hotels, restaurants, retail locations, healthcare facilities and other commercial and public spaces, supported by more than 100 designers. Oliver plans to list on the Tokyo Stock Exchange Standard Market on September 16, 2026.
The IPO was priced at JPY 305 per share, at the top of the JPY 295-305 range. The offering comprises approximately 74.1 million shares, raising approximately JPY 22.6 billion (approximately $142 million), before a potential 11.1 million-share overallotment. The offering consists entirely of secondary shares, with no primary shares being issued, meaning the proceeds from the base offering will go to selling shareholders rather than the company. The implied market capitalization at the offer price is approximately JPY 30.5 billion, or around $191 million.
Oliver’s largest shareholders include private equity-related entities Integral No. 4 Investment Limited Partnership, Initiative Delta IV L.P., Innovation Alpha IV L.P. and Integral Corporation. Daiwa Securities and Nomura Securities are the lead managers of the offering.
Holtec International (Ticker: HNUC US) is a U.S.-headquartered multinational clean-energy technology company focused primarily on nuclear power generation, nuclear services and advanced reactor technology. Holtec owns and is developing the SMR-300 small modular reactor and is refurbishing the Palisades nuclear power plant in Michigan, where it also plans to deploy its first two SMR-300 units. The company also provides engineering, licensing, manufacturing, construction, commissioning and decommissioning services to more than 150 nuclear reactors worldwide, and is expanding into solar energy and long-duration energy storage.
Holtec plans to list on Nasdaq on September 18, 2026, following pricing on September 17. The company is offering 50 million primary shares at $15.00-$18.00 per share, implying gross proceeds of approximately $850 million based on published terms. The offering is 100% primary. J.P. Morgan, Guggenheim, Goldman Sachs, Citi and Bank of America are serving as bookrunners. Holtec is founder-led, with Dr. Kris Singh serving as Founder, Chairman and CEO.
The IPOX® Newsletters
IPOX® in the News
IPOX® Associate Lukas Muehlbauer commented on the fall IPO market as Holtec Nuclear targets a valuation of up to $10.2 billion in its U.S. IPO. He said early deals could set the tone for the broader market, with strong debuts potentially encouraging more listings and weak pricing or aftermarket performance narrowing the window. Muehlbauer added that economic fundamentals, market conditions and the Federal Reserve’s September meeting are likely to drive IPO activity, with limited impact from midterm elections this year.
Reuters reports on SoftBank-backed SB Energy’s U.S. IPO filing as AI infrastructure investment accelerates. IPOX® Research Associate Lukas Muehlbauer comments on the company’s roughly $439 billion backlog, execution risks, and reliance on long-term customer commitments. He notes that investors must assess whether contracted demand can translate into future cash flow, while also weighing the uncertainty surrounding 20-year OpenAI leases in a rapidly evolving AI market and the sustainability of current infrastructure spending trends over the coming years.
IPOX® Associate Lukas Muehlbauer was featured in Bloomberg’s Mideast Money newsletter, providing context on Abu Dhabi’s recent moves to take strategic companies private. He highlighted how similar transactions in other markets have often reflected governments’ desire for greater control over important assets, whether to support long-term investment or restructuring. His comments helped frame the AD Ports and TAQA developments within a broader global pattern of state-led ownership consolidation and strategic market repositioning across public equity markets worldwide today and beyond.
German financial magazine FOCUS MONEY examines Oura’s planned IPO as the wearable technology company builds on strong growth and an expanding digital health platform. IPOX® Associate Lukas Muehlbauer comments on Oura’s positioning ahead of a potential listing, noting its evolution from a young wearable company into an established platform. He also highlights Oura’s focused product strategy versus larger technology groups, as the company targets further growth in the expanding global wearables market and recurring subscription-based customer revenue opportunities.
IPOX® CEO Josef Schuster commented on Lyntris’ New York debut after shares fell 11.4%, valuing the defense contractor at $1.78 billion. Schuster said the market was discounting the company’s capital structure rather than treating it like a venture capital deal. He also noted that higher U.S. bond yields were pushing investors away from riskier, less-seasoned companies, including recent IPOs, even as earnings remained strong. Lyntris priced its IPO below its marketed range and reduced the offering size to 17 million shares, raising $297.5 million.
The IPOX® Update
U.S. IPO activity is led by SB Energy’s planned $5 billion Nasdaq deal, alongside Cumberland Farms’ pre-IPO financing and Golden Pet Brands’ New York plans. In Europe, Nscale is raising $3.5 billion ahead of a potential flotation, while Blackstone prepares Hotel Investment Partners for a Spanish listing. Asia-Pacific remains especially active, with Moonshot AI, Asia OneHealthcare, Ligent, Club Med, Akulaku, Jollibee’s international unit and VinFast-linked GSM all advancing toward Hong Kong or Malaysian IPOs across technology, healthcare, hospitality and mobility.
This week’s IPOX Update highlights several major new listings across the U.S., Europe and Asia-Pacific. Oura is targeting a U.S. IPO of up to $3 billion, while Aggreko has filed for an NYSE listing that could raise about $1 billion. Ursa Major is pursuing a $2.3 billion SPAC transaction, and KNDS is considering reviving its European IPO. In Hong Kong, Syngenta remains a potential $10 billion candidate, while Medcaptain has launched its own offering ahead of a September market debut.
IPO activity accelerated across major markets, led by potentially record-sized U.S. offerings. Anthropic is preparing a public filing, while SB Energy targets at least $5 billion and General Atlantic revived listing plans. In Europe, Quantexa is weighing a London or U.S. IPO. Asia-Pacific activity includes a $1 billion Singapore data-center REIT and several Hong Kong technology listings. In Africa, Dangote Refinery advanced plans for a potential $5 billion Nigerian IPO after securing a $1 billion underwriting programme from its advisers.